Radioiodine therapy of cancer metastases?
Feldt-Rasmussen, U.F.
Ugeskrift for Laeger 163(24): 3367
2001
ISSN/ISBN: 0041-5782 PMID: 11434127 Document Number: 529452
Document emailed within 1 workday
Related Documents
Schiavo, M.; Bagnara, M.C.; Pomposelli, E.; Altrinetti, V.; Calamia, I.; Camerieri, L.; Giusti, M.; Pesce, G.; Reitano, C.; Bagnasco, M.; Caputo, M. 2013: Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 301-307Horácek, Jí. 2015: Radioiodine therapy in patients with low-thyroid cancer Vnitrni Lekarstvi 61(9): 755-757
Dietlein, M.; Dressler, J.; Farahati, J.; Leisner, B.; Moser, E.; Reiners, C.; Schicha, H.; Schober, O. 1999: Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer Nuklearmedizin. Nuclear Medicine 38(6a): 221-222
Birkenhake, S.; Sauer, R. 1994: Curative therapy in the presence of distant metastases. On the paper by H. Hawighorst et al. Cure in a patient with multiple osseus metastases in non-small cell lung cancer: a case report Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 170(1): 65
Grudeva-Popova, J.; Yaneva, M.; Zisov, K.; Ananoshtev, N. 2007: Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review Journal of BUON: Official Journal of the Balkan Union of Oncology 12(1): 129-132
Ronga, G.; Toteda, M.; D'Apollo, R.; De Cristofaro, F.; Filesi, M.; Acqualagna, G.; Argirò, R.; Ciancamerla, M.; Ugolini, F.; Montesano, T. 2012: Lymph node metastases from differentiated thyroid carcinoma: does radioiodine still play a role? La Clinica Terapeutica 163(5): 377-381
Zakani, A.; Saghari, M.; Eftekhari, M.; Fard-Esfahani, A.; Fallahi, B.; Esmaili, J.; Assadi, M. 2011: Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131i with emphasize on the thallium scintigraphy in these subgroups European Review for Medical and Pharmacological Sciences 15(10): 1215-1221
Watanabe, A.; Taniguchi, M. 2005: A case of oropharyngeal cancer with multiple bone metastases from prostate cancer that responded to docetaxel, ifosfamide and cisplatin combination therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 65-67
Urbannek, V.; Voth, E.; Moka, D.; Schicha, H. 2001: Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents NUKLEARMEDIZIN. Nuclear Medicine 40(4): 111-115
Fukuda, Y.; Fujio, N.; Ihara, T.; Takatori, H.; Tsukazaki, T.; Koyama, I.; Tsukazaki, Y.; Osugi, H. 2005: A case of cecal cancer with multiple liver metastases responding to irinotecan (CPT-11)/cisplatin (CDDP) combination therapy for elevation of CA19-9 after complete response (CR) by l-leucovorin(LV)/5-fluorouracil(5-FU) therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(12): 1949-1952
Bakheet, S.M.; Hammami, M.M.; Powe, J. 1996: False-positive radioiodine uptake in the abdomen and the pelvis: radioiodine retention in the kidneys and review of the literature Clinical Nuclear Medicine 21(12): 932-937
Köhler, A.H.; Dobberstein, N.; Stoltmann, R.; Heschel, U. 1984: Therapy of bone metastases in breast cancer Zentralblatt für Chirurgie 109(7): 483-489
Bláha, K. 1972: Problems of the therapy of laryngeal cancer metastases Casopis Lekaru Ceskych 111(49): 1147-1149
Borde, C.; Basu, S.; Kand, P.; Arya, S.; Shet, T. 2011: Bilateral renal metastases from papillary thyroid carcinoma on post 131i treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation Hellenic Journal of Nuclear Medicine 14(1): 72-73
Yaneva, M.P.; Semerdjieva, M.; Radev, L.R.; Ivanova, E.K.; Geiman, M.; Vlaikova, M.I.; Mihova, L.S. 2005: Radionuclide therapy of cancer patients with bone metastases Folia Medica 47(3-4): 63-69
Lorenz, M.; Wiesner, J.; Staib-Sebler, E.; Encke, A. 1995: Regional therapy breast cancer liver metastases Zentralblatt für Chirurgie 120(10): 786-790
Miyamoto, T.; Inoue, M.; Tanemura, M.; Yamaguchi, M.; Irei, T.; Tamaru, K.; Seo, S.; Misumi, T.; Shimizu, W.; Suzuki, T.; Onoe, T.; Sudo, T.; Shimizu, Y.; Hinoi, T.; Tashiro, H. 2018: A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 88-90
Morita, T.; Shibata, T.; Okuyama, M.; Ikeda, K.; Tsukahara, Y.; Kitada, M.; Nishikubo, M.; Ishida, T.; Shimano, T. 2004: Microwave coagulation therapy for liver metastases from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(5): 695-699
Kemeny, N. 1992: Review of regional therapy of liver metastases in colorectal cancer Seminars in Oncology 19(2 Suppl. 3): 155-162
Jurascheck, F. 1973: Vascular accidents of estrogen therapy for prostatic cancer metastases Journal d'Urologie et de Nephrologie 79(12 Part 2): 400-402